Systematic Biopsy of the Prostate can Be Omitted in Men with PI-RADS™ 5 and Prostate Specific Antigen Density Greater than 15.

Aged Humans Image-Guided Biopsy Male Middle Aged Multiparametric Magnetic Resonance Imaging Prostate / diagnostic imaging Prostate-Specific Antigen / blood Prostatic Neoplasms / diagnosis Unnecessary Procedures
diagnostic imaging image-guided biopsy magnetic resonance imaging multiparametric magnetic resonance imaging prostatic neoplasms

Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 6 4 2021
medline: 27 7 2021
entrez: 5 4 2021
Statut: ppublish

Résumé

We evaluated the prostate cancer and clinically significant prostate cancer detection on systematic biopsy (SB), target biopsy (TB) alone and combined SB and TB in men with Prostate Imaging Reporting and Data System™ (PI-RADS™) 5 lesion. From a prospectively maintained prostate biopsy database, we identified consecutive patients with PI-RADS 5 lesion on multiparametric magnetic resonance imaging. The patients underwent multiparametric magnetic resonance imaging followed by transrectal TB of PI-RADS 5 lesion and 12-core SB. The prostate cancer and clinically significant prostate cancer (Grade Group, GG ≥2) detection on SB, TB and SB+TB were determined for all men and accordingly to prostate specific antigen density. Statistic significant was set a p <0.05. Overall, 112 patients met inclusion criteria. The detection rate of prostate cancer for SB, TB and SB+TB was 89%, 93% and 95%, respectively, and for clinically significant prostate cancer it was 72%, 81% and 85%, respectively. SB added 2% prostate cancer and 4% clinically significant prostate cancer detection to TB. A total of 78 patients had prostate specific antigen density >0.15 ng/ml In patients with PI-RADS 5 on multiparametric magnetic resonance imaging and prostate specific antigen density >0.15 ng/ml

Identifiants

DOI: 10.1097/JU.0000000000001766 PMID: 33818141
pubmed: 33818141
doi: 10.1097/JU.0000000000001766
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

289-297

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Alessandro Tafuri (A)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.
Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Atsuko Iwata (A)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.
Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Aliasger Shakir (A)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.

Tsuyoshi Iwata (T)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.
Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Chhavi Gupta (C)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Akash Sali (A)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Dordaneh Sugano (D)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.

Abtahi Seyed Mahdi (AS)

Departments of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Giovanni E Cacciamani (GE)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.

Masatomo Kaneko (M)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.
Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Jie Cai (J)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.

Osamu Ukimura (O)

Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Vinay Duddalwar (V)

Departments of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Manju Aron (M)

Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Inderbir S Gill (IS)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.

Suzanne L Palmer (SL)

Departments of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Andre Luis Abreu (AL)

USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Center for Image-Guided and Focal Therapy for Prostate Cancer, University of Southern California, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Techniques d'investigation › Techniques cytologiques › Cytodiagnostic › Biopsie › Biopsie guidée par l'image › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Imagerie par résonance magnétique multiparamétrique › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Tissus › Glandes exocrines › Prostate › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Antigène spécifique de la prostate › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Systematic Biopsy of the Prostate can Be...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Attitude envers la santé › Mésusage des services de santé › Surmédicalisation › Procédures superflues › Systematic Biopsy of the Prostate can Be...